| Date Filed | Type | Description |
| 10/04/2023 |
8-K
| Investor presentation |
| 10/03/2023 |
8-K
| Other Events Interactive Data |
| 08/18/2023 |
4
| Heier Jeffrey S. (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Granted 17,350 options to buy
@ $4.3, valued at
$74.6k
|
|
| 08/07/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
8-K
| Quarterly results |
| 07/12/2023 |
4
| Graves Adrienne L (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Granted 24,000 shares
@ $0
Granted 72,000 options to buy
@ $5.04, valued at
$362.9k
|
|
| 07/12/2023 |
3
| Graves Adrienne L (Director) has filed a Form 3 on OCULAR THERAPEUTIX, INC |
| 07/12/2023 |
8-K
| Quarterly results |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2023 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
| 06/16/2023 |
4
| Warden Charles M (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Granted 12,000 shares
@ $0
Granted 36,000 options to buy
@ $5.31, valued at
$191.2k
|
|
| 06/16/2023 |
4
| Williams Leslie J. (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Granted 12,000 shares
@ $0
Granted 36,000 options to buy
@ $5.31, valued at
$191.2k
|
|
| 06/16/2023 |
4
| RAINES MERILEE (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Granted 12,000 shares
@ $0
Granted 36,000 options to buy
@ $5.31, valued at
$191.2k
|
|
| 06/16/2023 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Granted 12,000 shares
@ $0
Granted 36,000 options to buy
@ $5.31, valued at
$191.2k
|
|
| 06/16/2023 |
4
| Hong Seung Suh (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Granted 12,000 shares
@ $0
Granted 36,000 options to buy
@ $5.31, valued at
$191.2k
|
|
| 06/16/2023 |
4
| Heier Jeffrey S. (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Granted 12,000 shares
@ $0
Granted 36,000 options to buy
@ $5.31, valued at
$191.2k
|
|
| 06/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/12/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/08/2023 |
8-K
| Quarterly results |
| 05/01/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 05/01/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/01/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/06/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 03/06/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/06/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/06/2023 |
8-K
| Quarterly results |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 5.2% stake in Ocular Therapeutix Inc. |
| 02/08/2023 |
4
| White Christopher G (Chief Business Officer) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Sold 5,829 shares
@ $4.24, valued at
$24.7k
|
|
| 02/08/2023 |
4
| Ozden Rabia Gurses (Chief Medical Officer) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Sold 6,416 shares
@ $4.24, valued at
$27.2k
|
|
| 02/08/2023 |
4
| Notman Donald (CFO) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Sold 6,476 shares
@ $4.24, valued at
$27.5k
|
|
| 02/08/2023 |
4
| Strassburger Philip C. (General Counsel) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Sold 6,181 shares
@ $4.24, valued at
$26.2k
|
|
|